Copyright © 1980 by the European Society of Cardiology.
© 1980 The European Society of Cardiology
Beneficial effect of enhanced myocardial carbohydrate utilisation after oxfenicine (L-hydroxyphenylglycine) in angina pectoris
Cardiac Department King's College Hospital, London SE5, U.K.
Received 26 February 1980; .
Requests for reprints to: Dr G. Bergman, Cardiac Department, King's College Hospital, London SE5, U.K.
Although the major myocardial energy supply comes from oxidation of lipid, carbohydrate requires less oxygen for the same energy yield. Oxfenicine has been shown experimentally to favour carbohydrate utilisation and its effect in a dose of 3–12 mg/kg was studied in 18 patients with obstructive coronary artery disease, both at rest and during angina induced by rapid atrial pacing. No major haemodynamic changes or side effects were observed after the drug. The mean pacing time to angina was significantly increased from 289 ± 33 s to 360 ± 35 s (P < 0.05) and during pacing, myocardial oxygen consumption fell. After the drug there was a significant increase in myocardial extraction of carbohydrate in the form of lactate, pyruvate and glucose during pacing and in contrast, the myocardial extraction of free fatty acids fell significantly. This increase in myocardial carbohydrate extraction associated with a reduced myocardial oxygen consumption, is of potential value not only in the treatment of angina pectoris, but also in the early phases of acute myocardial infarction.
Key Words: Myocardial metabolism • coronary artery disease • L-hydroxyphenylglycine
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  W. C. Stanley, E. E. Morgan, H. Huang, T. A. McElfresh, J. P. Sterk, I. C. Okere, M. P. Chandler, J. Cheng, J. R. B. Dyck, and G. D. Lopaschuk Malonyl-CoA decarboxylase inhibition suppresses fatty acid oxidation and reduces lactate production during demand-induced ischemia Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2304 - H2309. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. C. Stanley, F. A. Recchia, and G. D. Lopaschuk Myocardial Substrate Metabolism in the Normal and Failing Heart Physiol Rev, July 1, 2005; 85(3): 1093 - 1129. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. C. Stanley Myocardial Energy Metabolism During Ischemia and the Mechanisms of Metabolic Therapies Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2004; 9(1_suppl): S31 - S45. [Abstract] [PDF]
|
|
|
|
 |
|
 M. P. Chandler, P. N. Chavez, T. A. McElfresh, H. Huang, C. S. Harmon, and W. C. Stanley Partial inhibition of fatty acid oxidation increases regional contractile power and efficiency during demand-induced ischemia Cardiovasc Res, July 1, 2003; 59(1): 143 - 151. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. N. Chavez, W. C. Stanley, T. A. McElfresh, H. Huang, J. P. Sterk, and M. P. Chandler Effect of hyperglycemia and fatty acid oxidation inhibition during aerobic conditions and demand-induced ischemia Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1521 - H1527. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Z. Martini, W. C. Stanley, H. Huang, C. D. Rosiers, C. L. Hoppel, and H. Brunengraber Quantitative assessment of anaplerosis from propionate in pig heart in vivo Am J Physiol Endocrinol Metab, February 1, 2003; 284(2): E351 - E356. [Abstract] [Full Text] [PDF]
|
|